A blood test has the potential to predict Alzheimer’s disease before patients start showing symptoms
In March of this year, a team of Georgetown University scientists published research showing that, for the first time ever, a blood test has the potential to predict Alzheimer’s disease before patients start showing symptoms. AACCis pleased to announce that a late-breaking session at the 2014 AACC Annual Meeting & Clinical Lab Expo in Chicago will expand upon this groundbreaking research and discuss why it could be the key to curing this devastating illness.
According to the World Health Organization, the number of Alzheimer’s patients worldwide is expected to skyrocket from the 35.6 million individuals who lived with it in 2010 to 115.4 million by 2050. Currently, however, all efforts to cure or effectively treat the disease have failed. Experts believe one explanation for this lack of success could be that the window of opportunity for treating Alzheimer’s has already closed by the time its symptoms manifest.